Nurami Medical is focused on developing revolutionary formulations to combat limitations found in existing surgical sealants and adhesives. These formulations are based on Nurami’s novel approach combining nanofibers and advanced bioactive materials which enhance healing and regeneration.
Nurami’s preliminary product is ArtiFascia®, a highly effective surgical patch with integrated temperature sensitive sealant, which is currently in the clinical stage and will be market ready in 2022. Our pipeline incudes ArtiFixTM, a soft tissue sealant patch which does not require suturing and a groundbreaking surgical adhesive for general surgery which will withstand premature degradation while adhering effectively to the wet environment of internal organs.
Pilot Clinical Trials
Pivot Clinical Trials
CE in 2021